| Analysis | Metabolite Name | Measured Value | Units | Model | Intervention |
|---|---|---|---|---|---|
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.00022 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.00025 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.00040 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.00054 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.00055 | peak area | Alzheimer’s disease model | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.00090 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.00094 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.0010 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.0014 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.0015 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.0015 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.0016 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.0026 | peak area | Wild type | Saline |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.0029 | peak area | Alzheimer’s disease model | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | 0.0055 | peak area | Wild type | B. breve MCC1274 |
| Normal phase UNSPECIFIED ION MODE | N-Acetylleucine | peak area | Wild type | Saline |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|